Panacea Biotec Complete Financial Statements
PANACEABIO • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Panacea Biotec (PANACEABIO).
Downloads include all available records across all periods.
For market performance, see the
PANACEABIO stock price today
.
Profitability Ratios
Net Profit Margin
-9.33%
2025 data
EBITDA Margin
-6.00%
2025 data
Operating Margin
-13.00%
2025 data
Return on Assets
-1.09%
2025 data
Return on Equity
-1.68%
2025 data
Balance Sheet Ratios
Current Ratio
5.92
2025 data
Debt to Equity
1.55
2025 data
Equity Ratio
64.42%
2025 data
Asset Turnover
0.12
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
-3.2%
Year-over-Year
Net Profit Growth
-380.0%
Year-over-Year
EBITDA Growth
-164.3%
Year-over-Year
Expense Growth
+13.6%
Year-over-Year
Assets Growth
+3.9%
Year-over-Year
Equity Growth
-0.8%
Year-over-Year
Liabilities Growth
+3.9%
Year-over-Year
Operating Cash Flow Growth
-775.0%
Year-over-Year
Investing Cash Flow Growth
+828.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 150 | 169 | 184 | 155 | 150 | 122 | 170 | 149 | 163 | 163 | 159 | 143 | 1,821 | 151 | 157 | 234 | 173 | 136 | 158 | 184 | 144 | 134 | 144 | 129 | 485 | 131 | 171 | 122 | 123 | 114 |
| Expenses | 159 | 159 | 168 | 140 | 143 | 130 | 156 | 147 | 135 | 140 | 151 | 109 | 171 | 191 | 124 | 226 | 167 | 134 | 144 | 144 | 150 | 111 | 127 | 149 | 258 | 104 | 132 | 179 | 116 | 87 |
| EBITDA | -9 | 9 | 16 | 14 | 8 | -8 | 14 | 2 | 29 | 24 | 8 | 34 | 1,650 | -40 | 33 | 8 | 6 | 2 | 14 | 40 | -6 | 23 | 17 | -20 | 228 | 27 | 39 | -57 | 7 | 27 |
| Operating Profit Margin % | -13.00% | -20.00% | -1.00% | 5.00% | -4.00% | -12.00% | 5.00% | -2.00% | -4.00% | -8.00% | 0.00% | -4.00% | -21.00% | -72.00% | -8.00% | 3.00% | 1.00% | -1.00% | 8.00% | 21.00% | -19.00% | 16.00% | 11.00% | -19.00% | -110.00% | 17.00% | 21.00% | -48.00% | -17.00% | 21.00% |
| Depreciation | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | 9 | 10 | 11 | 10 | 10 | 11 | 12 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | 13 | 11 | 11 | 14 | 14 | 52 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 31 | 1 | 1 | 50 | 47 | 48 | 52 | 48 | 45 | 45 | 46 | 42 | 26 | 41 | 47 | 29 | 25 | -14 |
| Profit Before Tax | -19 | 0 | 7 | 5 | -2 | -17 | 4 | -8 | 18 | 13 | -2 | 23 | 1,608 | -51 | 22 | -53 | -53 | -57 | -49 | -19 | -61 | -34 | -40 | -73 | 189 | -25 | -19 | -99 | -33 | -11 |
| Tax | -5 | 2 | 3 | 0 | 0 | -1 | 0 | 1 | 31 | 2 | 1 | 8 | 371 | 5 | 3 | 0 | 2 | 0 | 0 | 0 | 9 | 0 | 0 | 2 | 3 | 3 | 2 | -2 | 3 | 5 |
| Net Profit | -14 | -2 | 4 | 5 | -2 | -16 | 4 | -8 | -13 | 11 | -2 | 16 | 1,238 | -56 | 19 | -53 | -54 | -57 | -49 | -19 | -70 | -34 | -40 | -75 | 186 | -28 | -21 | -97 | -35 | -16 |
| Earnings Per Share (₹) | -2.27 | -0.31 | 0.66 | 0.77 | -0.23 | -2.59 | 0.74 | -1.35 | -2.03 | 1.79 | -0.37 | 2.56 | 202.03 | -9.17 | 3.16 | -8.65 | -8.84 | -9.36 | -8.03 | -3.16 | -11.38 | -5.58 | -6.54 | -12.25 | 30.35 | -4.62 | -3.48 | -15.83 | -5.75 | -2.60 |
Related Pages for Panacea Biotec
Additional stock information and data for PANACEABIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 1,290 | 1,241 | 1,271 | 1,759 | 1,178 | 1,390 | 1,376 | 1,608 | 1,800 | 1,854 | 1,931 |
| Current Assets | 545 | 486 | 562 | 951 | 511 | 683 | 508 | 560 | 533 | 549 | 526 |
| Fixed Assets | 567 | 582 | 600 | 622 | 609 | 657 | 806 | 949 | 1,001 | 1,071 | 1,144 |
| Capital Work in Progress | 128 | 102 | 42 | 17 | 34 | 24 | 23 | 40 | 30 | 161 | 156 |
| Investments | 3 | 40 | 14 | 5 | 0 | 6 | 5 | 7 | 7 | 4 | 5 |
| Other Assets | 592 | 517 | 615 | 1,115 | 534 | 703 | 542 | 611 | 761 | 619 | 626 |
| LIABILITIES | |||||||||||
| Total Liabilities | 1,290 | 1,241 | 1,271 | 1,759 | 1,178 | 1,390 | 1,376 | 1,608 | 1,800 | 1,854 | 1,931 |
| Current Liabilities | 92 | 94 | 101 | 109 | 960 | 743 | 90 | 611 | 846 | 930 | 750 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 831 | 838 | 840 | 874 | -232 | 196 | 347 | 306 | 366 | 450 | 475 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 22 | 22 |
| Reserves & Surplus | 807 | 814 | 816 | 849 | -257 | 139 | 335 | 293 | 340 | 426 | 449 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -27 | 4 | -423 | -108 | 107 | -31 | 105 | 118 | 131 | 91 | 37 |
| Investing Activities | 65 | 7 | 430 | 1,283 | -48 | -35 | -6 | 55 | -26 | 17 | -37 |
| Financing Activities | -3 | -3 | -18 | -1,176 | -47 | 91 | -101 | -164 | -107 | -117 | -1 |
| Net Cash Flow | 35 | 7 | -11 | -2 | 12 | 26 | -2 | 9 | -2 | -10 | -1 |